Urology · Wakefield, RI
NPI
1265489306
Since 2006
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
70 Kenyon Ave Ste 210
Wakefield, RI, 02879
Phone (401) 788-8780
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
834 services
Medicare patients, 2024
350
Average age 76
Drug cost, 2024
$593K
2,284 prescriptions
Company payments, 2025
$854
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leif E Olsson was code 99213 (office e&m - established), 328 times for 253 patients. In total Leif E Olsson billed 834 services in 46 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 328 | 253 | $59.13 | $19K |
| 99212 Office E&M - Established | Office | 145 | 109 | $41.48 | $6,014 |
| 52000 Cystourethroscopy | Office | 57 | 44 | $168.18 | $9,586 |
| 51798 Ultrasound - Nonspecific | Office | 41 | 36 | $7.15 | $293 |
| 99203 Office E&M - New | Office | 23 | 23 | $69.19 | $1,591 |
| 99231 Hospital E&M - Subsequent | Facility | 20 | 12 | $39.05 | $781 |
| 55700 Other Organ Systems | Facility | 14 | 14 | $96.91 | $1,357 |
| 99214 Office E&M - Established | Office | 14 | 14 | $88.17 | $1,234 |
| 52332 Cystourethroscopy | Facility | 13 | 11 | $107.35 | $1,396 |
| 99222 Hospital E&M - Initial | Facility | 13 | 11 | $94.67 | $1,231 |
| 81002 Clinical Chemistry | Office | 12 | 12 | $3.41 | $40.92 |
By year: 2022 $106K for 2,236 services; 2023 $77K for 1,298 services; 2024 $64K for 834 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 12 | 12 | $3.41 | $40.92 |
Medicare prescription drug claims, 2024
In 2024, the drug Leif E Olsson prescribed most often to Medicare patients was Tamsulosin Hcl, with 827 prescriptions and refills. In total Leif E Olsson wrote 2,284 Medicare prescriptions that cost $593K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 827 | 2,037 | 230 | $12K |
| Finasteride Generic | 608 | 1,671 | 179 | $9,327 |
| Cephalexin Generic | 111 | 111 | 78 | $637 |
| Ciprofloxacin Hcl Generic | 101 | 101 | 76 | $249 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 84 | 180 | 26 | $1,763 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 52 | 140 | 20 | $1,084 |
| Gemtesa Vibegron | 50 | 105 | 17 | $48K |
| Oxybutynin Chloride Generic | 49 | 82 | 13 | $604 |
| Myrbetriq Mirabegron | 41 | 51 | 13 | $23K |
| Dutasteride Generic | 37 | 102 | 21 | $1,435 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 33 | 33 | 17 | $348 |
| Xtandi Enzalutamide | 26 | 26 | Under 11 | $348K |
| Dutasteride-Tamsulosin Dutasteride/Tamsulosin Hcl | 21 | 38 | Under 11 | $3,177 |
| Eligard Leuprolide Acetate | 19 | 111 | 12 | $50K |
| Oxycodone Hcl Generic | 18 | 18 | 16 | $41.25 |
Brand drugs: 179 claims; generic drugs: 2,105 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leif E Olsson $854 ($854 in general payments such as food, travel and fees) from 15 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $120.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $120 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $100 |
| Abbvie Inc. ABBV | 4 | $90.42 |
| Tolmar, Inc. | 4 | $88.46 |
| Dendreon Pharmaceuticals LLC | 4 | $85.41 |
| Astellas Pharma US Inc 4503.T | 3 | $77.87 |
| Endo USA, Inc. | 2 | $58.2 |
| Blue Earth Diagnostics | 2 | $54.88 |
| Ferring Pharmaceuticals Inc. | 2 | $51.76 |
| Profound Medical Corp. PROF | 1 | $30 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.